Profile ng asset
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the tre…
Pinakabago muna.
Isinusulong ng Palatin ang PL2000 MC4R Agonist sa Phase 1 sa Unang Kalahati ng 2027
Iba pang gamot at kandidato ng parehong kumpanya na sinusubaybayan sa sektor na ito.